Today's Hospitalist

JUNE 7, 2025

THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. “You want someone who can monitor patients’ side effects and have a longitudinal relationship with them.”

Hospital 66

Hospital Management Diabetes Patients 66

GeriPal

OCTOBER 17, 2024

He was describing his, like, 87 year old grandma who was placed on a low salt diabetic diet. So I have a two and a half year old, and during my last pregnancy, I had gestational diabetes. If they’re frail, if they’re falling, if they have cognitive impairment, they’re at higher risk of adverse drug events.

Primary Care 113

Primary Care Patient-Centered IT Patients 113

GeriPal

AUGUST 1, 2024

Widera and Smith have no relationships to disclose. Guests Anna Pleet, Elizabeth Eckstrom, and Emily Johnston have no relationships to disclose. So if you already have a condition, you might be able to prevent events. The time it takes to look at chronic disease prevention or outcomes is just, it’s in the word chronic.

IT 116

IT Diabetes Chronic Disease Patient-Centered 116